Literature DB >> 10592946

Severe rhabdomyolysis following massive ingestion of oolong tea: caffeine intoxication with coexisting hyponatremia.

Y Kamijo1, K Soma, Y Asari, T Ohwada.   

Abstract

A 36-y-o patient with schizophrenia, who had consumed gradually increasing quantities of oolong tea that eventually reached 15 L each day, became delirious and was admitted to a psychiatric hospital. After abstinence from oolong tea his delirium resolved. He was transferred to our hospital when he was discovered to have acute renal failure with hyponatremia (118 mEq/L) and severe rhabdomyolysis (creatine phosphokinase, 227,200 IU/L). On admission rhabdomyolysis had begun to improve despite a worsening of the hyponatremia (113 mEq/L). With aggressive supportive therapy, including hypertonic saline administration and hemodialysis, the patient fully recovered without detectable sequelae. The clinical course suggests that caffeine, which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the delirium, although severe hyponatremia has been reported to cause rhabdomyolysis on rare occasions. We hypothesize that caffeine toxicity injured the muscle cells, which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis. The possibility of severe rhabdomyolysis should be considered in a patient with water intoxication due to massive ingestion of caffeine-containing beverages.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592946

Source DB:  PubMed          Journal:  Vet Hum Toxicol        ISSN: 0145-6296


  2 in total

1.  Plasma lactate concentration as an indicator of plasma caffeine concentration in acute caffeine poisoning.

Authors:  Seiji Morita; Takeshi Yamagiwa; Hiromichi Aoki; Keiji Sakurai; Sadaki Inokuchi
Journal:  Acute Med Surg       Date:  2014-04-23

2.  A review on renal toxicity profile of common abusive drugs.

Authors:  Varun Parkash Singh; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2013-07-30       Impact factor: 2.016

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.